Source: ALL
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
delta like canonical Notch ligand 4 | 0.494 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group L | 0.551 | 0.731 | 5.9E-23 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
Rho GTPase activating protein 31 | 0.581 | 0.615 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
dedicator of cytokinesis 6 | 0.610 | 0.577 | 1.3E-26 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
RAD51 recombinase | 0.447 | 0.846 | 2.7E-02 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 3 | 0.581 | 0.808 | 1.0E-10 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
collagen and calcium binding EGF domains 1 | 0.585 | 0.769 | 1.5E-07 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
X-ray repair cross complementing 2 | 0.512 | 0.731 | 4.0E-07 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
BRCA1 interacting protein C-terminal helicase 1 | 0.507 | 0.731 | 6.2E-17 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FAT atypical cadherin 4 | 0.539 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
partner and localizer of BRCA2 | 0.485 | 0.769 | 3.0E-19 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
SLX4 structure-specific endonuclease subunit | 0.565 | 0.731 | 1.6E-22 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
mitotic arrest deficient 2 like 2 | 0.547 | 0.731 | 8.2E-02 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
cystathionine beta-synthase | 0.465 | 0.885 | 3.1E-05 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
ADP ribosylation factor like GTPase 6 interacting protein 6 | 0.686 | 0.615 | 1.8E-02 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
von Hippel-Lindau tumor suppressor | 0.443 | 0.846 | 8.0E-02 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
RAD51 paralog C | 0.533 | 0.692 | 6.2E-14 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group I | 0.543 | 0.731 | 8.9E-37 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
ERCC excision repair 4, endonuclease catalytic subunit | 0.468 | 0.846 | 1.4E-12 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2004 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.050 | None | 1.000 | 5 | 1 | 2004 | 2018 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.050 | None | 1.000 | 5 | 1 | 1999 | 2018 | ||||||||
|
spermine synthase | 0.491 | 0.846 | 0.97 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2017 | 2020 |